Back to search results

Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA

IsraelRecruitingPHASE2

Conditions

Thrombotic Microangiopathies · Hematopoietic Stem Cell Transplantation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Omeros Investigational Site, San Diego, California, United States

  • Omeros Investigational Site, Gainesville, Florida, United States

  • Omeros Investigational Site, Boston, Massachusetts, United States

  • Omeros Investigational Site, St Louis, Missouri, United States

  • Omeros Investigational Site, New York, New York, United States

  • Omeros Investigational Site, Valhalla, New York, United States

  • Omeros Investigational Site, Houston, Texas, United States

  • Omeros Investigational Site, Seattle, Washington, United States

  • Omeros Investigational Site, Halle, Germany

  • Omeros Investigational Site, Hanover, Germany

  • Omeros Investigational Site, Haifa, Israel

  • Omeros Investigational Site, Jerusalem, Israel

  • Omeros Investigational Site, Ramat Gan, Israel

  • Omeros Investigational Site, Tel Aviv, Israel

  • Omeros Investigational Site, Utrecht, Netherlands

  • Omeros Investigational Site, Pamplona, Spain

View source on ClinicalTrials.gov(opens in a new tab)